Ultragenyx Pharmaceutical (RARE) Inventory (2017 - 2026)

Ultragenyx Pharmaceutical (RARE) has 10 years of Inventory data on file, last reported at $55.0 million in Q1 2026.

• On a quarterly basis, Inventory rose 19.48% year-over-year to $55.0 million in Q1 2026; TTM through Mar 2026 was $55.0 million, a 19.48% increase from a year earlier, with the FY2025 full-year figure at $52.0 million, up 15.56% from the prior year.
• Inventory for Q1 2026 stood at $55.0 million, up from $52.0 million in the prior quarter.
• Over the last five years, Inventory for RARE reached as high as $55.0 million in Q1 2026 and fell as low as $17.8 million in Q1 2022.
• Historically, Inventory has averaged $36.7 million across 5 years, with a median of $35.9 million in 2024.
• Across the five-year window, Inventory jumped 64.91% in 2022 and grew 15.56% in 2025, its largest moves.
• Year by year, Inventory stood at $26.8 million in 2022, then increased by 26.91% to $34.0 million in 2023, then soared by 32.47% to $45.0 million in 2024, then increased by 15.56% to $52.0 million in 2025, then rose by 5.77% to $55.0 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $55.0 million in Q1 2026, $52.0 million in Q4 2025, and $52.2 million in Q3 2025.